AI made execution free. Knowing first is the whole game now.
The advantage goes to whoever is first into the right conversations, most often. Fundz stacks those odds: more of the moments that create demand than anyone else catches, as they happen, matched to who you sell to, with the decision maker to call. Now it answers in Claude too: ask for today’s leads and who to reach, then write the note in the same window. Not a feed. Not a list you rent. A system for being first.
Trusted by
OracleSnowflakeCloudflareLinkedInGoogleSalesforce
★★★★★4.8/5 on G2· Since 2015
GLUCOTRACK, INC. Secures Funding through Direct Stock Offering
PUBLIC · GCTKSep 24, 2026
Amount Raised
$346,000
Round Type
Post-IPO Equity
IsraelBiotechnologyHealthcare
Investors
Institutional Investors
Description
On September 24, 2026, Glucotrack, Inc. entered into a securities purchase agreement with institutional investors to conduct a registered direct offering. The offering includes 169,388 shares of common stock and pre-funded warrants to purchase additional shares. The offering price per share is set at $2.04, providing significant capital for the company's initiatives.
Company Information
Company
Glucotrack
Location
19 HA'YAHALOMIM ST, P.O. BOX 12163
Israel
About
Glucotrack, Inc. is focused on the design, development, and commercialization of novel technologies for people with diabetes, including a long-term implantable continuous blood glucose monitoring system. The Glucotrack CBGM is an Investigational Device and is limited by federal (or United States) law to investigational use.
Fundz sees it the moment Glucotrack raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
IsraelBiotechnologyHealthcare